Indian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA Farhat Nasim14 Dec 2024 5:52 PM ISTLeading the market, Foracort, a respiratory drug widely used for asthma, secured the top position among brands with sales of Rs 82 crore.
Cetuximab outperforms durvalumab in treatment of head and neck cancers: Lancet Dr. Kamal Kant Kohli22 Nov 2024 8:30 PM ISTHead and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well...
USFDA accepts for priority review Bristol Myers Squibb application for Krazati, cetuximab combo for colorectal cancer Ruchika Sharma22 Feb 2024 1:30 PM ISTNew York: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental...
Alkem unveils Cetuximab under the Brand Name Cetuxa in India Dr. Nandita Mohan31 May 2023 11:23 AM ISTMumbai: One of India's leading drug makers, Alkem Labs, has announced the launch of the world's first Cetuximab biosimilar in the country under the...
Alkem Launches Cetuximab under the Brand Name Cetuxa in India Dr. Nandita Mohan30 May 2023 11:51 AM ISTMumbai: One of India's leading drug makers, Alkem Labs, has announced the launch of the world's first Cetuximab biosimilar in the country under the...
USFDA accepts Pfizer supplemental new drug applications for BRAFTOVI plus MEKTOVI Ruchika Sharma5 April 2023 12:00 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug...
